[Plasma concentration of peplomycin following intravenous infusion and subcutaneous infusion in patients with malignancies]

Gan To Kagaku Ryoho. 1984 Nov;11(11):2372-4.
[Article in Japanese]

Abstract

Five mg of peplomycin was administered continuously for 24 hours by intravenous or subcutaneous infusion. Subcutaneous administration of peplomycin was performed done with the use of an SP-5 microinfusion pump made by the in Nipro Company. The plasma concentration after intravenous infusion was 0.0106 +/- 0.039 microgram/ml, while that after subcutaneous infusion was 0.131 +/- 0.037 microgram/ml. There was no statistical significance between the differences observed for intravenous and subcutaneous infusion.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / blood*
  • Bleomycin / administration & dosage
  • Bleomycin / blood*
  • Esophageal Neoplasms / blood
  • Female
  • Humans
  • Infusions, Parenteral
  • Lymphoma / blood
  • Male
  • Neoplasms / blood*
  • Peplomycin
  • Prostatic Neoplasms / blood

Substances

  • Antibiotics, Antineoplastic
  • Bleomycin
  • Peplomycin